Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Transcend Therapeutics
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Completion of a double-blind Transcend-sponsored clinical trial with TSND-201 (e.g., TSND201-PTSD-301) and considered in good standing with the study site.
Proficient in communication (verbal and reading) to complete interviews and written questionnaires.
Agree to not participate in any other interventional clinical trials for the duration of this study.
You may not be if
Experienced an intolerable side effect following dosing with TSND-201 in the prior study.
Had significant deviation(s)/non-compliance in parent study in the opinion of the Investigator which would deem them unsuitable for participation.
Change or development of any physical or psychological finding that would make participant unsuitable for study.
Clareo Health | An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD
